ZORVOLEX®: A low-dose NSAID treatment option for patients with mild to moderate acute pain or osteoarthritis pain

ZORVOLEX®: The lowest FDA-approved dose of diclofenac available (18 mg)

ZORVOLEX is a nonsteroidal anti-inflammatory drug (NSAID) for patients with mild to moderate acute pain or osteoarthritis pain. Iroko Pharmaceuticals, LLC developed ZORVOLEX to align with recommendations from FDA, medical organizations, and advocacy groups: Use the lowest NSAID dose possible for the shortest time needed for your treatment.

Why ZORVOLEX®?

18 mg is the lowest FDA-approved dose of diclofenac available

ZORVOLEX was created using SoluMatrix Fine Particle Technology, a technology that helps drugs dissolve quickly so they can be rapidly absorbed by the body

Low-dose SoluMatrix® NSAIDs were developed by Iroko to align with recommendations from FDA, medical organizations, and advocacy groups: Use the lowest dose possible for the shortest time needed for your treatment

Do you know your NSAID dose?

Ask your doctor if you are taking the lowest dose possible for the treatment of mild to moderate acute pain or OA pain. Then ask about ZORVOLEX, the low-dose SoluMatrix® diclofenac from Iroko.

Ask Your Doctor About ZORVOLEX®

ZORVOLEX®: Clinical study results in patients with mild to moderate acute pain or osteoarthritis pain

In a clinical study, patients taking ZORVOLEX 18 mg or 35 mg three times daily:

  • Had greater reductions in pain compared with patients who took placebo

In a clinical study, patients taking ZORVOLEX 35 mg three times daily:

  • Experienced greater reductions in osteoarthritis pain compared with patients who took placebo

ZORVOLEX®: Possible side effects

Before beginning treatment with ZORVOLEX, it is important to be aware of potential side effects and to discuss these potential problems with your doctor

  • In clinical studies, the most common side effects reported with ZORVOLEX were swelling, nausea, headache, dizziness, vomiting, constipation, itching, diarrhea, gas, leg or foot pain, abdominal pain, stuffy or runny nose, abnormal blood tests, high blood pressure, and heartburn

ZORVOLEX®: Dosing and administration

ZORVOLEX is FDA-approved at low, 18-mg and 35-mg doses administered 3 times daily:

  • In clinical studies, patients taking ZORVOLEX had greater reductions in osteoarthritis pain and mild to moderate acute pain compared with patients who took placebo
  • ZORVOLEX can be used for management of mild to moderate acute pain at low doses of 18 mg and 35 mg 3 times daily
  • ZORVOLEX can be used for management of osteoarthritis pain at a dose of 35 mg 3 times daily

ZORVOLEX was developed to align with recommendations from FDA, medical organizations, and advocacy groups: Use the lowest NSAID dose possible for the shortest time needed for your treatment.

Do you know your NSAID dose?

Ask your doctor if you are taking the lowest dose possible for the treatment of mild to moderate acute pain or OA pain. Then ask about ZORVOLEX, the low-dose SoluMatrix® diclofenac from Iroko.

Ask Your Doctor About ZORVOLEX®

Eligible* patients
pay as little as
$10

*Terms and Conditions may apply.